858122 | 16:0 Lyso PG
1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt)

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
16:0 Lyso PG
1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt)
CAS Registry Number is a Registered Trademark of the American Chemical Society
PG(16:0/0:0)
110711
Siriwardane DA, Wang C, Jiang W, Mudalige T. Quantification of phospholipid degradation products in liposomal pharmaceutical formulations by ultra performance liquid chromatography-mass spectrometry (UPLC-MS). Int J Pharm. 2020 Jan 24;578:119077. doi: 10.1016/j.ijpharm.2020.119077. Epub ahead of print. PMID: 31988036.
PubMed ID: 31988036Shi Q, Jin S, Xiang X, Tian J, Huang R, Li S, Chen C, Xu H, Song C. The metabolic change in serum lysoglycerophospholipids intervened by triterpenoid saponins from Kuding tea on hyperlipidemic mice. Food Funct. 2019 Dec 11;10(12):7782-7792. doi: 10.1039/c9fo02142f.
PubMed ID: 31782452Yan Y, Du Z, Chen C, Li J, Xiong X, Zhang Y, Jiang H. Lysophospholipid profiles of apolipoprotein E-deficient mice reveal potential lipid biomarkers associated with atherosclerosis progression using validated UPLC-QTRAP-MS/MS-based lipidomics approach. J Pharm Biomed Anal. 2019 Jul 15;171:148-157. doi: 10.1016/j.jpba.2019.03.062. Epub 2019 Apr 5.
PubMed ID: 30999225Pedersen JN, Jiang Z, Christiansen G, Lee JC, Pedersen JS, Otzen DE. Lysophospholipids induce fibrillation of the repeat domain of Pmel17 through intermediate core-shell structures. Biochim Biophys Acta Proteins Proteom. 2018 Nov 22. pii: S1570-9639(18)30205-X. doi: 10.1016/j.bbapap.2018.11.007. [Epub ahead of print].
PubMed ID: 30471451Zhao R, Kennedy K, De Blas GA, Orta G, Pavarotti MA, Arias RJ, de la Vega-Beltrán JL, Li Q, Dai H, Perozo E, Mayorga LS, Darszon A, Goldstein SAN. Role of human Hv1 channels in sperm capacitation and white blood cell respiratory burst established by a designed peptide inhibitor. Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11847-E11856. doi: 10.1073/pnas.1816189115. Epub 2018 Nov 26.
PubMed ID: 30478045Stafford, R.E., Fanni, T., Dennis, E.A. (1989) Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry. 28(12):5113-20. [PubMed]
PubMed ID: 2669968Huang, P., Liu, Q., Scarborough, G.A. (1998) Lysophosphatidylglycerol: a novel effective detergent for solubilizing and purifying the cystic fibrosis transmembrane conductance regulator. Anal Biochem. 259(1):89-97. [PubMed]
PubMed ID: 9606148- Certificate of Analysis (Lot No. 858122P-1G-A-084 and 5851PQA084)
- Certificate of Analysis (Lot No. 858122P-500MG-A-083 and 5851PPA083)
- Certificate of Analysis (Lot No. 858122P-500MG-A-084 and 5851PPA084)
- Certificate of Analysis (Lot No. 858122P-500MG-B-084 and 5851PPB084)
- Certificate of Analysis (Lot No. 858122P-1G-B-084 and 5851PQB084)
- Certificate of Analysis (Lot No. 858122P-500MG-C-084 and 5851PPC084)
- Certificate of Analysis (Lot No. 858122P-500MG-A-085 and 5851PPA085)
- Certificate of Analysis (Lot No. 858122P-1G-A-085 and 5851PQA085)
- Certificate of Analysis (Lot No. 858122P-500MG-B-085 and 5851PPB085)
- Certificate of Analysis (Lot No. 858122P-1G-A-086 and 5851PQA086)
- Certificate of Analysis (Lot No. 858122P-500MG-A-086 and 5851PPA086)
- Certificate of Analysis (Lot No. 858122P-500MG-A-087 and 5851PPA087)
- Certificate of Analysis (Lot No. 858122P-500MG-B-087 and 5851PPB087)
- Certificate of Analysis (Lot No. 858122P-500MG-A-088 and 5851PPA088)
- Certificate of Analysis (Lot No. 858122P-1G-B-087 and 5851PQB087)
- Certificate of Analysis (Lot No. 858122P-1G-C-089 and 5851PQC089)
- Certificate of Analysis (Lot No. 858122P-500MG-C-089 and 5851PPC089)
- Certificate of Analysis (Lot No. 858122P-500MG-A-089 and 5851PPA089)
- Certificate of Analysis (Lot No. 858122P-1G-B-089 and 5851PQB089)
- Certificate of Analysis (Lot No. 858122P-500MG-B-089 and 5851PPB089)
- Certificate of Analysis (Lot No. 858122P-1G-D-089 and 5851PQD089)
- Certificate of Analysis (Lot No. 858122P-500MG-D-089 and 5851PPD089)
- Certificate of Analysis (Lot No. 858122P-500MG-A-090 and 5851PPA090)